Articles Tagged With:
-
Nursing Claims More Severe, Defense More Expensive
Claims involving nursing care are becoming more severe, with treatment or care allegations remaining the top concern, according to the Nurse Professional Liability Claim Report, 5th edition from Nurses Service Organization (NSO) in Fort Washington, PA.
-
States Passing New Restrictions on Health Data Sharing
There is a rapidly expanding wave of state consumer-health-privacy laws reshaping how retailers, wellness brands, e-commerce companies, and digital platforms must handle data that can reveal or infer a person’s health status. These laws reach far beyond HIPAA and apply even when a business provides no medical services.
-
How to Investigate an Adverse Event
How you investigate adverse events can determine how valuable your efforts are in the end. Paying attention to best practices for these investigations can increase your chances of finding useful information that leads to meaningful change.
-
Documentation Do’s and Don’ts: Know What Really Matters
“Document, document, document!” is the mantra of healthcare risk management. If it was not documented, did it really happen? If it was documented, was it documented properly? Knowing the right and wrong ways to document can make the difference when defending a malpractice claim or conducting a root cause investigation.
-
Substance Withdrawal
Drug withdrawal syndromes are a frequent and challenging presentation in emergency departments, with a spectrum ranging from mild discomfort to severe, life-threatening complications. Emergency physicians must recognize and appropriately manage these syndromes, often with limited information and under acute clinical urgency. Despite established guidelines, inconsistencies remain in recognizing when withdrawal syndromes require inpatient stabilization vs. outpatient management. This article reviews the four most encountered withdrawal syndromes — alcohol, opioids, sedatives, and antidepressants — focusing on practical, evidence-based strategies for evaluation, treatment, and disposition in the emergency department.
-
Infectious Disease Updates
DoxyPEP and Antimicrobial Resistance; Emergence of Resistance to Cefepime-Zidebactam
-
Modified mRNA Influenza Vaccine Shows Superior Efficacy Over Standard Inactivated Vaccine
In a Phase III randomized controlled trial of adults aged 18 to 64 years, a quadrivalent nucleoside-modified messenger ribonucleic acid (mRNA) (modRNA) influenza vaccine demonstrated 34.5% relative efficacy against laboratory-confirmed influenza-like illness compared with a licensed inactivated influenza vaccine, meeting criteria for both noninferiority and superiority. The modRNA platform showed enhanced immunogenicity against influenza A strains and strong T-cell responses but did not meet noninferiority criteria for immunogenicity against influenza B strains (although clinical efficacy against B strains could not be determined due to low case counts). The modRNA vaccine was associated with increased reactogenicity but demonstrated an acceptable safety profile, supporting the potential of mRNA technology for next-generation influenza vaccines.
-
One vs. Two Doses of HPV Vaccine
A single dose of either of two human papillomavirus vaccines was as effective as administration of two doses.
-
Steroids for Community-Acquired Pneumonia in Africa
A randomized clinical trial from Kenya found that adult patients with community-acquired pneumonia who received standard care plus a 10-day course of glucocorticoids had a modest decrease in 30-day mortality compared to standard care alone (22.6% vs. 26.0%, respectively; P = 0.02).
-
Transplanted Rabies
The Centers for Disease Control and Prevention describes the fourth donor-organ rabies transmission event in the United States.